{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:38:05Z","timestamp":1792366685643,"version":"4.4.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver diseases, including viral hepatitis, alcoholic liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC), represent a significant threat to global health due to their high mortality rates. The cGAS-STING pathway, a critical part of the innate immune system, plays a crucial role in detecting cytoplasmic DNA and initiating immune responses, including autoimmune inflammation and antitumor immunity. Genomic instability during cancer progression can trigger this pathway by releasing DNA into the cytoplasm. Emerging research indicates that cGAS-STING signaling is intricately involved in maintaining liver homeostasis and contributes to the pathogenesis of various liver diseases. This review outlines the cGAS-STING pathway, with a particular focus on its activation mechanism and its roles in several notable liver conditions. Specifically, we explore the complex interplay of cGAS-STING signaling in viral hepatitis, ALD, MASLD, and HCC, and discuss its potential as a therapeutic target. For example, in HCC, strategies targeting cGAS-STING include using nanomaterials to deliver STING agonists, combining radiofrequency ablation (RFA) with cGAS-STING activation, and leveraging radiotherapy to enhance pathway activation. Furthermore, modulating cGAS-STING activity may offer therapeutic avenues for viral hepatitis and chronic liver diseases like MASLD and ALD, either by boosting antiviral responses or mitigating inflammation. This review highlights the complex role of cGAS-STING signaling in these specific liver diseases and underscores the need for further research to fully realize its therapeutic potential.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1498323","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:04:08Z","timestamp":1740985448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeting cGAS-STING: modulating the immune landscape of hepatic diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Feng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Gong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-He","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719644","article-title":"cGAS-STING signaling pathway and liver disease: from basic research to clinical practice","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"New Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1470-2045(22)00326-6","article-title":"Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial","volume":"23","author":"Kelley","year":"2022","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2022.06.058","article-title":"Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials","volume":"174","author":"Fulgenzi","year":"2022","journal-title":"Eur J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.07.005","article-title":"Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death","volume":"12","author":"Zheng","year":"2022","journal-title":"Acta Pharm Sinica B"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0774-19.2019","article-title":"Accumulation of cytoplasmic DNA due to ATM deficiency activates the microglial viral response system with neurotoxic consequences","volume":"39","author":"Song","year":"2019","journal-title":"J Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41467-018-03555-8","article-title":"Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15027","article-title":"Formation of adenovirus DNA replication compartments and viral DNA accumulation sites by host chromatin regulatory proteins including NPM1","volume":"287","author":"Genoveso","year":"2020","journal-title":"FEBS J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682736","article-title":"The cGAS-STING pathway: novel perspectives in liver diseases","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216409","article-title":"cGAS-STING signaling in the tumor microenvironment","volume":"577","author":"Liu","year":"2023","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature10802","article-title":"DNA breaks and chromosome pulverization from errors in mitosis","volume":"482","author":"Crasta","year":"2012","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-18-0689","article-title":"Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer","volume":"9","author":"Kitajima","year":"2019","journal-title":"Cancer Discovery"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24033029","article-title":"How the innate immune DNA sensing cGAS-STING pathway is involved in apoptosis","volume":"24","author":"Zheng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413232","article-title":"How the innate immune DNA sensing cGAS\u2013STING pathway is involved in autophagy","volume":"22","author":"Zheng","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review","volume":"22","author":"Oura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.775462","article-title":"Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges","volume":"9","author":"Hao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00262-018-2131-2","article-title":"Defective HLA class I antigen processing machinery in cancer","volume":"67","author":"Cai","year":"2018","journal-title":"Cancer immunol immunother: CII"},{"key":"B26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-020-1144-6","article-title":"Predictive biomarkers and mechanisms underlying resistance to PD1\/PD-L1 blockade cancer immunotherapy","volume":"19","author":"Ren","year":"2020","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0374-6","article-title":"Can we harness the microbiota to enhance the efficacy of cancer immunotherapy","volume":"20","author":"Finlay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1399926","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29133121","article-title":"Agonists and inhibitors of the cGAS-STING pathway","volume":"29","author":"Yu","year":"2024","journal-title":"Molecules"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1114","article-title":"Direct effects of type I interferons on cells of the immune system","volume":"17","author":"Hervas-Stubbs","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.201900237","article-title":"A dual role of type I interferons in antitumor immunity","volume":"4","author":"Zhou","year":"2020","journal-title":"Adv Biosyst"},{"key":"B37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01261","article-title":"Type I interferon receptor on NK cells negatively regulates interferon-\u03b3 Production","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0059-5","article-title":"Intratumoral IFN-\u03b1 gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression","volume":"26","author":"Hirata","year":"2019","journal-title":"Cancer Gene Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2672","article-title":"CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice","volume":"17","author":"Zoglmeier","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004006","article-title":"Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC","volume":"10","author":"Li","year":"2022","journal-title":"J ImmunoTher Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1108-8","article-title":"The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma","volume":"39","author":"Thomsen","year":"2020","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210440","article-title":"A DNA\/DMXAA\/metal-organic framework activator of innate immunity for boosting anticancer immunity","volume":"35","author":"Chen","year":"2023","journal-title":"Adv Mater"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.08.010","article-title":"Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA","volume":"8","author":"Gao","year":"2014","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2024.01.048","article-title":"STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment","volume":"369","author":"Ao","year":"2024","journal-title":"J Controlled Release: Off J Controlled Release Soc"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1021\/acs.jmedchem.3c01785","article-title":"Simultaneous activation of immunogenic cell death and cGAS-STING pathway by liver- and mitochondria-targeted gold(I) complexes for chemoimmunotherapy of hepatocellular carcinoma","volume":"67","author":"Li","year":"2024","journal-title":"J Med Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02354-2","article-title":"Smart responsive Fe\/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation","volume":"22","author":"Du","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c08064","article-title":"A booster for radiofrequency ablation: advanced adjuvant therapy via in situ nanovaccine synergized with anti-programmed death ligand 1 immunotherapy for systemically constraining hepatocellular carcinoma","volume":"17","author":"Tian","year":"2023","journal-title":"ACS nano"},{"key":"B50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12951-023-02170-0","article-title":"Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation","volume":"21","author":"Cao","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111769","article-title":"Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathway","volume":"130","author":"Sun","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216507","article-title":"Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma","volume":"582","author":"Chen","year":"2024","journal-title":"Cancer Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308009","article-title":"RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma","volume":"11","author":"Hong","year":"2024","journal-title":"Adv Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","article-title":"The changing epidemiology of liver diseases in the Asia-Pacific region","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/v13081463","article-title":"Mechanism of hepatitis B virus cccDNA formation","volume":"13","author":"Wei","year":"2021","journal-title":"Viruses"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.01.001","article-title":"Global epidemiology of viral hepatitis","volume":"49","author":"Razavi","year":"2020","journal-title":"Gastroenterol Clinics North America"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01263-15","article-title":"Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes","volume":"90","author":"Cui","year":"2016","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01481-15","article-title":"Alteration of mature nucleocapsid and enhancement of covalently closed circular DNA formation by hepatitis B virus core mutants defective in complete-virion formation","volume":"89","author":"Cui","year":"2015","journal-title":"J Virol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13563","article-title":"The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly","volume":"283","author":"Dansako","year":"2016","journal-title":"FEBS J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00771-17","article-title":"Activation of stimulator of interferon genes in hepatocytes suppresses the replication of hepatitis B virus","volume":"61","author":"Guo","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30054","article-title":"Hepatitis B virus evasion from cyclic guanosine monophosphate-adenosine monophosphate synthase sensing in human hepatocytes","volume":"68","author":"Verrier","year":"2018","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0629-6","article-title":"Nuclear cGAS suppresses DNA repair and promotes tumorigenesis","volume":"563","author":"Liu","year":"2018","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.abc5386","article-title":"Phosphorylation and chromatin tethering prevent cGAS activation during mitosis","volume":"371","author":"Li","year":"2021","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2749-z","article-title":"The molecular basis of tight nuclear tethering and inactivation of cGAS","volume":"587","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0237","article-title":"Structural basis for the inhibition of cGAS by nucleosomes","volume":"370","author":"Kujirai","year":"2020","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02760-14","article-title":"Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000647","article-title":"Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway","volume":"97","author":"He","year":"2016","journal-title":"J Gen Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04321-14","article-title":"STING agonists induce an innate antiviral immune response against hepatitis B virus","volume":"59","author":"Guo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1096\/fba.1022","article-title":"High-level expression of STING restricts susceptibility to HBV by mediating type III IFN induction","volume":"1","author":"Dansako","year":"2019","journal-title":"FASEB Bioadv"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500839","article-title":"Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice","volume":"195","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002061","article-title":"Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis","volume":"7","author":"Sitia","year":"2011","journal-title":"PloS Pathog"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2019.03.013","article-title":"Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand","volume":"531","author":"Ito","year":"2019","journal-title":"Virology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00652","article-title":"A telomerase-derived peptide exerts an anti-hepatitis B virus effect via mitochondrial DNA stress-dependent type I interferon production","volume":"11","author":"Choi","year":"2020","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116427","article-title":"Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication","volume":"311","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e28966","DOI":"10.1002\/jmv.28966","article-title":"HBV confers innate immune evasion through triggering HAT1\/acetylation of H4K5\/H4K12\/miR-181a-5p or KPNA2\/cGAS-STING\/IFN-I signaling","volume":"95","author":"Zhao","year":"2023","journal-title":"J Med Virol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00408-9","article-title":"WHO hepatitis C elimination targets: the global equity challenge","volume":"9","author":"Heath","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67714","article-title":"Emerging concepts in immunity to hepatitis C virus infection","volume":"123","author":"Rosen","year":"2013","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216100","article-title":"Suppression of innate immunity by the hepatitis C virus (HCV): revisiting the specificity of host\u2013virus interactive pathways","volume":"24","author":"Barik","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.26017","article-title":"Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity","volume":"57","author":"Nitta","year":"2013","journal-title":"Hepatology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.019","article-title":"Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity","volume":"59","author":"Ding","year":"2013","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01720-15","article-title":"Hepatitis C virus NS4B can suppress STING accumulation to evade innate immune responses","volume":"90","author":"Yi","year":"2016","journal-title":"J Virol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/508295a","article-title":"Hepatitis C drugs not reaching poor","volume":"508","author":"Callaway","year":"2014","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.001","article-title":"Hepatitis C reinfection after sustained virological response","volume":"64","author":"Midgard","year":"2016","journal-title":"J Hepatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1302","article-title":"MEDICINE. Global control of hepatitis C virus","volume":"349","author":"Cox","year":"2015","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1400986","article-title":"Curing chronic hepatitis C\u2013the arc of a medical triumph","volume":"370","author":"Chung","year":"2014","journal-title":"New Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1086\/655902","article-title":"Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins","volume":"202","author":"Ray","year":"2010","journal-title":"J Infect Dis"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.072","article-title":"Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes","volume":"35","author":"Landi","year":"2017","journal-title":"Vaccine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpgasthep0084","article-title":"Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease","volume":"2","author":"Sanyal","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J Gastroenterol : WJG"},{"key":"B95","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1053\/j.gastro.2004.09.021","article-title":"Obesity and hepatocellular carcinoma","volume":"127","author":"Caldwell","year":"2004","journal-title":"Gastroenterology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J Clin Invest"},{"key":"B99","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ccell.2018.03.027","article-title":"Extrinsic phagocyte-dependent STING-signaling dictates the immunogenicity of dying cells","volume":"33","author":"Ahn","year":"2018","journal-title":"Cancer Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-019-0342-6","article-title":"STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"100","author":"Wang","year":"2020","journal-title":"Lab Investig; J Tech Methods Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2018.11.097","article-title":"The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING","volume":"25","author":"Li","year":"2018","journal-title":"Cell Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e2105465118","DOI":"10.1073\/pnas.2105465118","article-title":"STING inhibitors target the cyclic dinucleotide binding pocket","volume":"118","author":"Hong","year":"2021","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00466","article-title":"Discovery of a novel cGAMP competitive ligand of the inactive form of STING","volume":"10","author":"Siu","year":"2019","journal-title":"ACS med Chem Lett"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.114975","article-title":"Gelsevirine improves age-related and surgically induced osteoarthritis in mice by reducing STING availability and local inflammation","volume":"198","author":"Feng","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e53932","DOI":"10.15252\/embr.202153932","article-title":"CDK inhibitor Palbociclib targets STING to alleviate autoinflammation","volume":"23","author":"Gao","year":"2022","journal-title":"EMBO Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.03.034","article-title":"Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING","volume":"526","author":"Li","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-021-00559-3","article-title":"Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages","volume":"17","author":"Cao","year":"2022","journal-title":"Chin Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.cmet.2020.04.011","article-title":"Low-dose sorafenib acts as a mitochondrial uncoupler and ameliorates nonalcoholic steatohepatitis","volume":"31","author":"Jian","year":"2020","journal-title":"Cell Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.07.028","article-title":"Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling","volume":"623","author":"Huang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911870117","article-title":"Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation","volume":"117","author":"Luther","year":"2020","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01220-5","article-title":"The dual function of cGAS-STING signaling axis in liver diseases","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.95","article-title":"Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression","volume":"95","author":"Miyao","year":"2015","journal-title":"Lab Investig; J Tech Methods Pathol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nature12640","article-title":"Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP","volume":"503","author":"Ablasser","year":"2013","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1498323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:04:13Z","timestamp":1740985453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1498323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2025.1498323"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1498323","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"article-number":"1498323"}}